Neuronetics, Inc.
General ticker "STIM" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $82.5M (TTM average)
Neuronetics, Inc. does not follow the US Stock Market performance with the rate: -23.7%.
Estimated limits based on current volatility of 9.9%: low 1.41$, high 1.72$
Factors to consider:
- Total employees count: 203 (+4.6%) as of 2023
- Top business risk factors: Lack of profitability, Management of rapid expansion, Market competition, Labor/talent shortage/retention, Implementation of new systems or technology
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.86$, 2.87$]
- 2026-12-31 to 2027-12-31 estimated range: [0.79$, 2.57$]
Financial Metrics affecting the STIM estimates:
- Positive: with PPE of -2.4 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0 <= 0.28
- Positive: Shareholder equity ratio, % of 15.81 <= 19.24
- Negative: negative Net income
Short-term STIM quotes
Long-term STIM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $71.35MM | $74.89MM | $149.16MM |
| Operating Expenses | $101.90MM | $109.45MM | $180.59MM |
| Operating Income | $-30.55MM | $-34.56MM | $-31.44MM |
| Non-Operating Income | $0.36MM | $-9.18MM | $-7.70MM |
| Interest Expense | $5.42MM | $7.29MM | $8.41MM |
| R&D Expense | $9.52MM | $12.77MM | $6.58MM |
| Income(Loss) | $-30.19MM | $-43.74MM | $-39.13MM |
| Taxes | $0.00MM | $-0.01MM | $0.00MM |
| Net Income(Loss)* | $-30.19MM | $-43.71MM | $-39.00MM |
| Stockholders Equity | $34.19MM | $27.71MM | $22.38MM |
| Inventory | $8.09MM | $4.25MM | $4.33MM |
| Assets | $115.83MM | $140.90MM | $141.55MM |
| Operating Cash Flow | $-32.04MM | $-31.00MM | $-20.37MM |
| Capital expenditure | $2.37MM | $1.47MM | $0.80MM |
| Investing Cash Flow | $-1.32MM | $-2.41MM | $-0.80MM |
| Financing Cash Flow | $22.70MM | $-6.81MM | $35.85MM |
| Earnings Per Share** | $-1.05 | $-1.38 | $-0.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.